1. Home
  2. FLGT vs KIO Comparison

FLGT vs KIO Comparison

Compare FLGT & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • KIO
  • Stock Information
  • Founded
  • FLGT 2011
  • KIO 2011
  • Country
  • FLGT United States
  • KIO United States
  • Employees
  • FLGT N/A
  • KIO 2400
  • Industry
  • FLGT Medical Specialities
  • KIO Investment Managers
  • Sector
  • FLGT Health Care
  • KIO Finance
  • Exchange
  • FLGT Nasdaq
  • KIO Nasdaq
  • Market Cap
  • FLGT 587.3M
  • KIO 506.5M
  • IPO Year
  • FLGT 2016
  • KIO N/A
  • Fundamental
  • Price
  • FLGT $18.07
  • KIO $12.48
  • Analyst Decision
  • FLGT Buy
  • KIO
  • Analyst Count
  • FLGT 2
  • KIO 0
  • Target Price
  • FLGT $24.00
  • KIO N/A
  • AVG Volume (30 Days)
  • FLGT 210.6K
  • KIO 136.5K
  • Earning Date
  • FLGT 08-01-2025
  • KIO 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • KIO 10.82%
  • EPS Growth
  • FLGT N/A
  • KIO N/A
  • EPS
  • FLGT N/A
  • KIO N/A
  • Revenue
  • FLGT $292,448,000.00
  • KIO N/A
  • Revenue This Year
  • FLGT $11.79
  • KIO N/A
  • Revenue Next Year
  • FLGT $10.45
  • KIO N/A
  • P/E Ratio
  • FLGT N/A
  • KIO N/A
  • Revenue Growth
  • FLGT 1.71
  • KIO N/A
  • 52 Week Low
  • FLGT $14.57
  • KIO $10.52
  • 52 Week High
  • FLGT $25.11
  • KIO $13.59
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 29.01
  • KIO 55.36
  • Support Level
  • FLGT $19.18
  • KIO $12.44
  • Resistance Level
  • FLGT $19.96
  • KIO $12.58
  • Average True Range (ATR)
  • FLGT 0.56
  • KIO 0.06
  • MACD
  • FLGT -0.15
  • KIO -0.02
  • Stochastic Oscillator
  • FLGT 0.86
  • KIO 31.25

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About KIO KKR Income Opportunities Fund

KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.

Share on Social Networks: